About 2,855 results

ALLMedicine™ Cervical Screening Center

Research & Reviews  970 results

Cervical cancer risk factors in eight west African countries: cross-sectional analysis ...
Lancet (London, England); Olajide N, Robb K et. al.

Mar 18th, 2023 - Cervical cancer is the fourth most common cancer in women worldwide. We aimed to assess the burden of cervical cancer risk factors among women in eight west African countries. Cross-sectional data from nationally representative samples of eight we...

Attitudes to reducing cervical screening frequency among UK women: A qualitative analysis.
Psycho-oncology Rickford R, Rogers M et. al.

Mar 2nd, 2023 - Cervical cancer remains a significant health threat amongst women globally despite most cervical cancers being preventable through screening and Human Papilloma Virus (HPV) vaccination. With the introduction of HPV testing and vaccination, evidenc...

Colposcopy for cervical screening in low-resource settings.
The Lancet. Global Health; de Sanjose S

Feb 17th, 2023 - Colposcopy for cervical screening in low-resource settings.|2023|de Sanjose S,|diagnosis,prevention & control,diagnosis,diagnosis,

Adherence to Cervical Cancer Screening Programs in Migrant Populations: A Systematic Re...
International Journal of Environmental Research and Publi... Rosato I, Dalla Zuanna T et. al.

Feb 12th, 2023 - Organized cervical cancer screening programs to promote the early identification of precancerous lesions have proven to be effective in decreasing the burden associated with cervical cancer, but knowledge regarding screening adherence among migran...

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV v...
BMC Medicine; Choi HCW, Leung K et. al.

Feb 12th, 2023 - Regarding primary and secondary cervical cancer prevention, the World Health Organization proposed the cervical cancer elimination strategy that requires countries to achieve 90% uptake of human papillomavirus (HPV) vaccines and 70% screening upta...

see more →

Guidelines  2 results

Colposcopic management of abnormal cervical cytology and histology.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Bentley J, et. al.

Dec 13th, 2012 - To provide a guideline for managing abnormal cytology results after screening for cervical cancer, to clarify the appropriate algorithms for follow-up after treatment, and to promote the best possible care for women while ensuring efficient use of...

Cervical screening: a guideline for clinical practice in Ontario.
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Murphy J, Kennedy EB et. al.

May 5th, 2012 - To develop guidelines to inform the Ontario Cervical Screening Program's invitations to women in the target population, provide evidence-based clinical practice guidance for practitioners, and inform policy decisions. A systematic review was condu...

see more →

Clinicaltrials.gov  57 results

Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia

Feb 6th, 2023 - Compass is a randomised controlled trial of primary HPV testing for cervical cancer screening versus cytology screening in Australia. A pilot study involving 5,000 women was carried out in 2013-2014. The main trial will involve recruiting 76,300 w...

Follow-up of Cell Changes in the Cervix

Feb 2nd, 2023 - The aim of the study is to clarify whether follow-up of cell changes is carried out with sufficiently good quality. It is nationally recommended to perform an HPV test on mild cell changes and only refer to clinical follow-up if you are HPV positi...

Community Based Interventions to Improve HIV Outcomes in Youth: a Cluster Randomised Trial in Zimbabwe

Jan 27th, 2023 - Young people fare disproportionately poorly across the HIV care continuum compared to other age-groups; the prevalence of undiagnosed HIV is substantially higher, and coverage of and adherence to antiretroviral therapy is lower, resulting overall ...

Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care

Jan 20th, 2023 - Identifying premalignant and benign diseases of the cervix and selecting an appropriate treatment path can be challenging. The adult uterine cervix may exhibit a wide variety of pathologic conditions that include benign entities (eg, cervicitis, h...

Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls

Nov 4th, 2022 - In Denmark, women aged 23-49 are offered cervical screening with liquid-based cytology (LBC) every 3rd year, and women aged 50-59 every 5th year. Women aged 60-64 are offered an exit HPV-DNA test. In 2008 vaccination against Human papilloma virus ...

see more →

News  113 results

5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Women

Jun 3rd, 2022 - Women ages 24 to 49 who initially test negative for the human papillomavirus (HPV) can be safely screened for cervical cancer at 5-year intervals, according to results from a U.K. study. Using data from the first and second rounds of the English H...

Shift to HPV Testing Will Require Public Education

May 19th, 2022 - The shift from Papanicolaou (Pap) cytology to direct testing for the human papillomavirus (HPV) represents a major advance in cervical cancer screening. Nevertheless, some experts like Emily Delpero, MD, of Mount Sinai Hospital in Toronto, Canada,...

We Must Improve Communication With the Public

May 2nd, 2022 - The scienctific community has been in some ways stunningly ineffective in clearly communicating highly relevant information about the COVID-19 virus and pandemic to the public. Several factors help explain this discouraging state of affairs, inclu...

Cheap and Noninvasive: Detecting HPV in Sanitary Pads

Apr 19th, 2022 - A cell phone rings in a red-brick bungalow in a village in India. A woman on the other end of the phone tells Ms. SK, a community health worker, that menstruation has started. Ms. SK guns her scooter through the dusty streets for 15 minutes in 30 ...

Breast, Cervical Screening Suboptimal in Transgender Individuals

Mar 11th, 2022 - NEW YORK (Reuters Health) - Transgender (TG) individuals were less likely than cisgender (CG) individuals to undergo screening for breast and cervical cancer despite their increased risk for these conditions, researchers say. "Population studies s...

see more →